Even if the tumor spread-promoting effect of Bevacizumab is under debate (122), nevertheless, these data bear witness to a close interaction between tumor hypoxia and SDF-1/CXCR4 signaling as introduced in more detail in the next chapter. This evidence concerns the gene CXCL12 and neoplasm.